Market Access Interview Interviewer: Rachael Hellman Interviewee: Colin Taggart While pharma companies are continuously innovating internal processes and implementing novel technologies to gain efficiencies across R&D and commercial, one function [...]
New product expands Clarify’s Growth Solution for life sciences companies, delivering comprehensive real-world insights software for the acceleration of therapy commercialization Clarify Health, a leading cloud analytics and value-based payments [...]
The FDA’s latest draft guidance on diversity and inclusion in clinical trials Diversity within the US continues to grow, with four in 10 Americans identifying with a race or ethnic [...]
pGHD is a medical condition that affects a child’s puberty and physical development. Somatropin injections are used to treat pGHD, improve growth in childhood, and prevent or improve metabolic impairments [...]
Clarify Health published a real-world study assessing medication adherence among patients with heart disease caused by transthyretin amyloid cardiomyopathy (ATTR-CM). The study titled “Baseline Characteristics and Secondary Medication Adherence Patterns [...]